View : 158 Download: 0
In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method
- In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method
- Kyung H.R.; Su J.C.; Yoon J.J.; Ju Y.S.; Jeong H.K.; Sang H.K.; Hyoung J.K.; Hyo S.A.; Hee Y.S.
- Ewha Authors
- 서주영; 유경하; 조수진
- SCOPUS Author ID
- 서주영; 유경하; 조수진
- Issue Date
- Journal Title
- International Journal of Hematology
- International Journal of Hematology vol. 80, no. 3, pp. 281 - 286
- SCIE; SCOPUS
- Document Type
- Dendritic cells (DCs) are the most potent antigen-presenting cells in terms of initiating primary T-cell-dependent immune responses. We devised a 2-step culture method for obtaining sufficient numbers of functional DCs from umbilical cord blood (CB) CD34+ cells. In the first step, CB CD34+ cells were expanded by stimulation with early-acting cytokines such as stem cell factor (SCF), flt3 ligand (FL), and thrombopoietin (TPO) to amplify the hematopoietic progenitor cells. In the second step, granulocyte-macrophage colony-stimulating factor and interleukin 4 were added, and incubation was continued for another 5 days to induce differentiation of the expanded cells into DCs. During the first step of culturing with TPO, SCF, and FL, the total numbers of nucleated cells gradually increased, peaking at 4 weeks (245.3-fold). During the second step, expression of CD1a, CD83, and CD86 increased. Electron microscopic findings showed that these cells had cytosolic expansion to form dendrites and major histocompatibility complex class II compartments, which are characteristic of DCs. Functional analyses revealed that these cells had phagocytic activity and were capable of stimulating allogeneic T-cells in vitro. © 2004 The Japanese Society of Hematology.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.